BiotechTube

Hemorrane plus + Hemorrane + Placebo

Phase 3Terminated
0 watching 0 views this week📈 Rising
72
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
✓
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Haemorrhoids Without Complication

Conditions

Haemorrhoids Without Complication

Trial Timeline

Mar 30, 2023 → Jan 4, 2024

NCT ID
NCT05788497

About Hemorrane plus + Hemorrane + Placebo

Hemorrane plus + Hemorrane + Placebo is a phase 3 stage product being developed by Faes Farma for Haemorrhoids Without Complication. The current trial status is terminated. This product is registered under clinical trial identifier NCT05788497. Target conditions include Haemorrhoids Without Complication.

Hype Score Breakdown

Clinical
27
Activity
18
Company
5
Novelty
9
Community
10

Clinical Trials (1)

NCT IDPhaseStatus
NCT05788497Phase 3Terminated

Other Products from Faes Farma

Bilastine + Desloratadine + PlaceboPhase 3
72
Bilastine Ophthalmic Solution 0.6% + Ketotifen Ophthalmic Solution 0.025% (Zaditen) + Vehicle of Bilastine Ophthalmic SolutionPhase 3
72
MesalazinePhase 3
72
Bilastine + PlaceboPhase 3
72
bilastine + Cetirizine + PlaceboPhase 3
72